The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression

Psychoneuroendocrinology

Volumn 28, Issue 3, 2003, Pages 376-385

  Zwanzger, P ^a   Baghai, T C ^a   Padberg, F ^a   Ella, R ^a   Minov, C ^a   Mikhaiel, P ^a   Schule C ^a   Thoma, H ^a   Rupprecht, Rainer ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

ACTH; Cortisol; DEX CRH test; HPA axis; Major depression; RTMS

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN RELEASE; FEMALE; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE RELEASE; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OPEN STUDY; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELAPSE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 0037390221     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(02)00029-X     Document Type: Article

References (30)

1. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Arch Gen Psychiat. 42:1985;1193-1204.
2. Ben Shachar D., Belmaker R.H., Grisaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. J. Neural Transm. 104:1997;191-197.
3. Ben Shachar D., Gazawi H., Riboyad-Levin J., Klein E. Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res. 816:1999;78-83.
4. Berman R.M., Narasimhan M., Sanacora G., Miano A.P., Hoffman R.E., Hu X.S., Charney D.S., Boutros N.N. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiat. 47:2000;332-337.
5. Garcia-Toro M., Mayol A., Arnillas H., Capllonch I., Ibarra O., Crespi M., Mico J., Lafau O., Lafuente L. Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J. Affect. Disord. 64:2001;271-275.
6. George M.S., Wassermann E.M., Kimbrell T.A., Little J.T., Williams W.E., Danielson A.L., Greenberg B.D., Hallett M., Post R.M. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. J. Psychiat. 154:1997;1752-1756.
7. George M.S., Lisanby S.H., Sackeim H.A. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiat. 56:1999;300-311.
8. George M.S., Nahas Z., Molloy M., Speer A.M., Oliver N.C., Li X.B., Arana G.W., Risch S.C., Ballenger J.C. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiat. 48:2000;962-970.
9. Grunhaus L., Dannon P.N., Schreiber S., Dolberg O.H., Amiaz R., Ziv R., Lefkifker E. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biol Psychiat. 47:2000;314-324.
10. Gur E., Lerer B., Dremencov E., Newman M.E. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport. 11:2000;2925-2929.
11. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 28:1994;341-356.
12. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am J. Psychiat. 153:1996;93-99.
13. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
14. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62:2001;77-91.
15. Keck M.E., Sillaber I., Ebner K., Welt T., Toschi N., Kaehler S.T., Singewald N., Philippu A., Elbel G.K., Wotjak C.T., Holsboer F., Landgraf R., Engelmann M. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin biogenic amines and amino acids in the rat brain. Eur. J. Neurosci. 12:2000;3713-3720.
16. Keck M.E., Engelmann M., Muller M.B., Henniger M.S., Hermann B., Rupprecht R., Neumann I.D., Toschi N., Landgraf R., Post A. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J. Psychiatr. Res. 34:2000;265-276.
17. Keck M.E., Welt T., Post A., Muller M.B., Toschi N., Wigger A., Landgraf R., Holsboer F., Engelmann M. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology. 24:2001;337-349.
18. Kole M.H., Fuchs E., Ziemann U., Paulus W., Ebert U. Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats. Brain Res. 826:1999;309-312.
19. Klein E., Kreinin I., Chistyakov A., Koren D., Mecz L., Marmur S., Ben Shachar D., Feinsod M. Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiat. 56:1999;315-320.
20. Nemeroff C.B. The role of corticotropin-releasing factor in the pathogenesis of major depression. Pharmacopsychiatry. 21:1988;76-82.
21. Padberg F., Schule C., Zwanzger P., Baghai T.C., Ella R., Mikhaiel P., Hampel H., Moller H.J., Rupprecht R. Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression. J. Psychiatr. Res. 36:2002;131-135.
22. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;233-237.
23. Pridmore S. Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test. Psychiat Clin Neurosci. 53:1999;33-37.
24. Ribeiro S.C., Tandon R., Grunhaus L., Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am J. Psychiat. 150:1993;1618-1629.
25. Rupprecht R., Lesch K.P., Muller U., Beck G., Beckmann H., Schulte H.M. Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. J. Clin. Endocrinol. Metab. 69:1989;600-603.
26. Sackeim H.A., Rush A.J., George M.S., Marangell L.B., Husain M.M., Nahas Z., Johnson C.R., Seidman S., Giller C., Haines S., Simpson R.K., Goodman R.R. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 25:2001;713-728.
27. Schule C., Baghai T., Zwanzger P., Minov C., Padberg F., Rupprecht R. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients. J. Psychiatr. Res. 35:2001;239-247.
28. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation June 5-7, 1996. Electroencephalogr. Clin. Neurophysiol. 108:1998;1-16.
29. Zobel A.W., Yassouridis A., Frieboes R.M., Holsboer F. Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. Am J. Psychiat. 156:1999;949-951.
30. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. J. Psychiatr. Res. 35:2001;83-94.